Status | Study |
Completed |
Study Name: Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets Condition: Primary Hypophosphatemic Rickets Date: 2010-11-07 Interventions: Drug: Z-521 |
Active, not recruiting |
Study Name: Hypophosphatemic Rickets in Norway Condition: Hypophosphatemia, Familial Rickets Date: 2010-01-26 Interventions: Dietary Supplement: Alfacalcidol; phosphate. |
Completed |
Study Name: A Study of KRN23 in X-linked Hypophosphatemia Condition: X-linked Hypophosphatemia Date: 2009-01-27 Interventions: Drug: Placebo single dose IV o |
Completed |
Study Name: Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4 Condition: Chronic Kidney Disease Date: 2008-10-01 Interventions: Other: grain (soy) protein diet |
Completed |
Study Name: Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets Condition: Hypophosphatemic Rickets Growth Disorders Somatropin Thera Date: 2007-05-11 Interventions: Drug: somatropin |
Completed |
Study Name: Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets Condition: Hypophosphatemia, Familial Hyperparathyroidism Date: 2006-12-28 Interventions: Drug: Paricalcitol Paricalcito |
Recruiting |
Study Name: Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project. Condition: Date: 2024-04-29 |
Completed |
Study Name: A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia Condition: Date: 2024-04-29 |
Active, not recruiting |
Study Name: Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH) Condition: Date: 2024-04-29 |
Completed |
Study Name: Calcitonin for Treating X-linked Hypophosphatemia Condition: Date: 2024-04-29 |